New therapies for muscular dystrophy: cautious optimism
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (10) , 516-520
- https://doi.org/10.1016/j.molmed.2004.08.007
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Glucocorticoid corticosteroids for Duchenne muscular dystrophyPublished by Wiley ,2004
- The new frontier in muscular dystrophy research: booster genesThe FASEB Journal, 2003
- Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potentialNature Cell Biology, 2003
- Wnt Signaling Induces the Myogenic Specification of Resident CD45+ Adult Stem Cells during Muscle RegenerationCell, 2003
- Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID miceBlood, 2002
- The muscular dystrophiesPublished by Elsevier ,2002
- Muscular Dystrophy—Reason for Optimism?Cell, 2002
- Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?Journal of Clinical Investigation, 2000
- Dystrophin expression in the mdx mouse restored by stem cell transplantationNature, 1999
- Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblastsNature, 1989